520 3rd Ave SW, Suite 1900, Centennial Place, East Tower, Calgary, AB
Year called to bar: 2002 (ON); 2005 (AB)
Robb is a partner at the national law firm of Borden Ladner Gervais LLP in the M&A and Capital Markets Group. Robb has been very active in technology and health sciences. He provides strategic and legal advice to some of the most cutting edge companies in both sectors. In 2021, he advised on nine such listings and public financings. Robb is a national leader in public listings on the NEO and TSX. He has been a leader in innovation and his accomplishments include RTO structures for NEO listings, and the first trust and international capital pool companies, among other things. Robb is a member of the TSX Venture Exchange Local Advisory Committee. Robb's professional experience includes working as the vice-president of Strategy and Corporate Operations at Assante Corporation, a financial services company formerly listed on the Toronto Stock Exchange that was sold to CI Financial for approximately $850 million. He was previously an executive of a large private company in Japan. Robb has sat on multiple public and private company boards of directors (including technology and health science boards) and has a large shareholder activism practice specializing in hostile and special situations.